Stimulant Use Disorder: From Neurobiology to Public Health - 2023

5 (5 votes)

  • Register
    • Non-Member - $39
    • Regular Member - $29
    • Retired - $29
    • Early Career Physician - $29
    • Resident - $19
    • Student - $19
    • Associate - $19
    • ASAM Staff - Free!
    • International Member - $29
    • Emeritus Member - $29
    • Provisional Member - $29
    • Fellow Member - $29
    • Honorary Member - $29
    • CRT Member - $29
image

Stimulant Use Disorder: From Neurobiology to Public Health

Recorded: Thursday, July 27, 2023 - Friday, July 28, 2023
On-Demand Session

Overview

This 45-minute, on-demand session from the ASAM 2023 Review Course addresses stimulants by describing their methods of use, pharmacological effects, and clinical approaches to treating adverse effects and stimulant use disorder.

While addiction treatment providers continue to fight the opioid overdose epidemic, there has been a growing resurgence in stimulant use. This session is designed to describe the methods of use, pharmacological effects, and molecular mechanisms of action for stimulant drugs, including cocaine, methamphetamine and newer "bath salts" cathinones. The presenter will also discuss clinical approaches for treating adverse effects and stimulant use disorders. After this session, learners will be able to explain the physiologic effects of stimulants, epidemiology of stimulant use, and emerging options for evidence-based treatment.

The target audience for this introductory and intermediate-level activity includes: Physicians preparing for the ABPM or AOA Board Certification Examination in addiction medicine, nurse practitioners, physician assistants, other clinicians, researchers, residents, fellows, students, and counselors.

This activity addresses the following ACGME Competencies: Patient Care, Medical Knowledge, and Practice-Based Learning.

Learning Objectives

Upon completion, learners will be able to:

  1. Demonstrate practical knowledge on the neurobiology of addiction and articulate its activity in terms useful in a clinical setting.
  2. Describe the effects of alcohol, tobacco and other drugs in both tolerant and non-tolerant individuals.
  3. Describe the process for diagnosing addiction and differentiating the symptoms of addiction from those of other medical or psychiatric disorders.
  4. Explain the various pharmacologic and psychosocial treatments for addictive disorders and describe the factors that should be considered in selecting a treatment modality to match the needs of a specific patient.
  5. Describe the precipitants of relapse and current evidence-based practices to prevent and manage relapse.

Registration Rates

Rate DescriptionRate
ASAM Member$29
Non-Member$39
Associate Member$19
Resident Member*$19
Student Member*$19

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM e-Learning Center refund requests must be made in writing to education@asam.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or e-Learning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Deadline: 07/31/2026
Registrant Access Closed: 07/31/2026

Course Instructions

  1. Click on the Contents tab to watch the on-demand recording.
  2. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 2 out of 3 questions correctly.
  3. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
  4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer Essential Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

Michael H. Baumann

PhD

Michael H. Baumann, PhD is a Staff Scientist and Chief of the Designer Drug Research Unit (DDRU), at the Intramural Research Program (IRP) of the National Institute on Drug Abuse (NIDA) in Baltimore, Maryland.  The DDRU collects, analyzes and disseminates the most up-to-date information about the pharmacology and toxicology of newly-emerging synthetic drugs of abuse (i.e., designer drugs), more formally known as new psychoactive substances (NPS).  Working with partner organizations such as the Drug Enforcement Administration (DEA) and the National Drug Early Warning System (NDEWS), Dr. Baumann is kept informed about trends in the misuse of NPS.  The DDRU has characterized the molecular mechanism of action and pharmacological effects for a diversity of NPS, including “bath salts” (synthetic stimulants), “spice” (synthetic cannabinoids) and synthetic opioids.  Findings from the DDRU inform law enforcement personnel, health care workers, clinical toxicologists, forensic scientists, basic researchers, and policymakers who are involved in responding to the global spread of NPS and the associated public health risks. 


No Relevant Financial Disclosures

ACCME Accredited with Commendation

CME, CE, CEU and Other Credit Types

ACCME Accreditation Statement

The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The American Society of Addiction Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1225

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205

California Consortium of Addiction Programs and Professionals (CCAPP)

This educational program is approved by CCAPP: #OS-20-330-1224

Continuing Education Credits (CEUs)

Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

Maintenance of Certification (MOC) or Continuing Certification Programs (CCP)

This activity meets the requirements for MOC/CCP for the following primary physician boards and for state licensing CME requirements. MOC Credit is only reported for ABA, ABP, ABIM, and ABS. Learn more.

  • American Board of Medical Specialties (ABMS)
  • American Board of Preventive Medicine (ABPM)
  • American Board of Anesthesiology (ABA)
  • American Board of Internal Medicine (ABIM)
  • American Board of Pediatrics (ABP)
  • American Board of Surgery (ABS)
  • American Board of Psychiatry and Neurology (ABPN)
  • American Board of Addiction Medicine (ABAM)
  • Royal College of Physicians and Surgeons of Canada (RCPSC)

Disclosure Information

In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include mitigating all possible relevant financial relationships with ineligible companies for the Planning Committees and Presenters. All activity Planning Committee member and Presenters have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity. View all faculty disclosure information here.

Key:

Complete
Failed
Available
Locked
View On-Demand Recording
Open to view video.  |   Closed captions available  |  45 minutes
Open to view video.  |   Closed captions available  |  45 minutes Video is approximately 45 minutes long. Recorded between 07/27/23 - 07/28/23.
Listen to Audio Recording (Optional)
Open to listen to or download MP3 audio.  |  45 minutes
Open to listen to or download MP3 audio.  |  45 minutes Audio is approximately 45 minutes long. Recorded between 07/27/23 - 07/28/23.
Complete Post Test
3 Questions  |  10 attempts  |  2/3 points to pass
3 Questions  |  10 attempts  |  2/3 points to pass This post-test has 3 questions and requires 2 out of 3 to pass the quiz.
Complete Evaluation
19 Questions
19 Questions Scroll down on evaluation, there may be questions that expand past the size of the window.
Claim Credits & Certificate
Up to 0.75 medical credits available  |  Certificate available
Up to 0.75 medical credits available  |  Certificate available Participants should claim only the credit commensurate with the extent of their participation in the activity.